Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks
Go back to Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 3.12 +0.24 (8.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.88 | 52 Week High | $9.58 | |||
| Open | $3.01 | 52 Week Low | $2.34 | |||
| Day High | $3.16 | P/E | N/A | |||
| Day Low | $2.94 | EPS | $-0.34 | |||
| Volume | 437,313 | |||||
